Cargando…
Mechanism-Based Pharmacokinetic Model for the Deglycosylation Kinetics of 20(S)-Ginsenosides Rh2
Aim: The 20(S)-ginsenoside Rh2 (Rh2) is being developed as a new antitumor drug. However, to date, little is known about the kinetics of its deglycosylation metabolite (protopanoxadiol) (PPD) following Rh2 administration. The aim of this work was to 1) simultaneously characterise the pharmacokinetic...
Autores principales: | Ren, Hong-can, Sun, Jian-guo, A, Ji-ye, Gu, Sheng-hua, Shi, Jian, Shao, Feng, Ai, Hua, Zhang, Jing-wei, Peng, Ying, Yan, Bei, Huang, Qing, Liu, Lin-sheng, Sai, Yang, Wang, Guang-ji, Yang, Cheng-guang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175024/ https://www.ncbi.nlm.nih.gov/pubmed/35694247 http://dx.doi.org/10.3389/fphar.2022.804377 |
Ejemplares similares
-
Transcriptome Analyses of the Anti-Proliferative Effects of 20(S)-Ginsenoside Rh2 on HepG2 Cells
por: Zhang, Ji, et al.
Publicado: (2019) -
The interaction of serum albumin with ginsenoside Rh2 resulted in the downregulation of ginsenoside Rh2 cytotoxicity
por: Lin, Yingjia, et al.
Publicado: (2017) -
Integrative network pharmacology and experimental verification to reveal the anti-inflammatory mechanism of ginsenoside Rh4
por: To, Kwang-Il, et al.
Publicado: (2022) -
Pharmacokinetic Comparison of 20(R)- and 20(S)-Ginsenoside Rh1 and 20(R)- and 20(S)-Ginsenoside Rg3 in Rat Plasma following Oral Administration of Radix Ginseng Rubra and Sheng-Mai-San Extracts
por: Fan, Xiaomei, et al.
Publicado: (2017) -
Ginsenoside Rh2 attenuates microglial activation against toxoplasmic encephalitis via TLR4/NF-κB signaling pathway
por: Xu, Xiang, et al.
Publicado: (2020)